Myeloid cells are a key source of IL-23, and CD64 has recently emerged as a surface marker of IL-23–producing myeloid cells residing within inflamed tissues in PsO and IBD (20, 29, 30). This evidence concerns the gene FCGR1A and inflammatory bowel disease.